Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms
Authors:
- Arif A. ShukrallaASArif A. Shukralla
- Catrin Tudur-SmithCTCatrin Tudur-Smith
- Graham A. PowellGPGraham A. Powell
- Paula R. WilliamsonPWPaula R. Williamson
- Anthony G. MarsonAMAnthony G. Marson
- 30 November 2011
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 97 (1-2) , 20-29
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Reporting of Harm in Randomized Controlled Trials Published in the Urological LiteratureJournal of Urology, 2010
- Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic reviewJournal of Antimicrobial Chemotherapy, 2009
- The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatryContemporary Clinical Trials, 2009
- CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and ElaborationPLOS Medicine, 2008
- Quality of reporting Randomized Controlled Trials (RCTs) in the nursing literature: Application of the Consolidated Standards of Reporting Trials (CONSORT)Nursing Outlook, 2008
- The Use of the World Wide Web by Medical Journals in 2003 and 2005: An Observational StudyPediatrics, 2007
- Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT StatementAnnals of Internal Medicine, 2004
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and ElaborationAnnals of Internal Medicine, 2001
- Better reporting of randomised controlled trials: the CONSORT statementBMJ, 1996
- Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.Psychological Bulletin, 1968